Preparation and characterization of acrylic acid/itaconic acid hydrogel coatings containing silver nanoparticles

Hydrogel silver nanocomposites have been used in applications with excellent antibacterial performance. Acrylic acid (AA)/itaconic acid (IA) hydrogels silver nanocomposites were prepared and applied as a coating on a textile substrate. Hydrogel matrices were synthesized first by the polymerization of an AA/IA aqueous (80/20 v/v) solution and mixed with 2‐2‐azobis(2‐methylpropionamide) diclorohydrate and N,N′‐methylene bisacrylamide until the hydrogel was formed. Silver nanoparticles were generated throughout the hydrogel networks with an in situ method via the incorporation of the silver ions and subsequent reduction with sodium borohydride. Cotton (C) and cotton/polyester (CP) textile fibers were then coated with these hydrogel silver nanocomposites. The influence of these nanocomposite hydrogels on the properties of the textile fiber were investigated by infrared spectroscopy (attenuated total reflectance), scanning electron microscopy, energy‐dispersive X‐ray spectroscopy, and antibacterial tests against Pseudomona aeruginosa and Staphylococcus aureus. The better conditions, in which no serious aggregation of the silver nanoparticles occurred, were determined. It was proven that the textiles coated with hydrogels containing nanosilver had an excellent antibacterial abilities. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 130: 2713–2721, 2013     

FC-16B催化剂在加氢裂化装置上的应用

介绍了中国石油大庆石化公司炼油厂加氢裂化装置概况、主要技术特点及工艺流程,探讨了装置开工过程,包括催化剂的装填、干燥、硫化、钝化、原料油切换等的各个主要节点,并通过标定对FC-16B催化剂的处理能力、操作参数、物料平衡、产品收率、装置能耗及设备运行状况进行考察。标定和运行结果表明,FC-16B催化剂性能良好,对原料适应性强,加工方案灵活,产品质量优良且分布合理,液体收率、加工损失率都在指标要求范围内,能耗远低于设计指标。     

Validation of a UV Spectrophotometric Method for Determination of Proteolytic Activity of Enzymatic Detergents

Enzymatic detergents are widely used in health services. These products should be controlled to ensure their activity. In this paper, a UV spectrophotometric method for the determination of proteolytic activity in enzymatic detergents was validated. An artificial substrate (azocasein) was used to quantify the enzyme activity at 340 nm. The results showed that the method was satisfactory in respect to its specificity, linearity, precision, accuracy and robustness. This method fulfills both ICH’s and Brazilian criteria, demonstrating its suitability for routine analysis as well as its potential application for regulatory purposes.     

高浓度氰化物废水处理的研究和应用

对某企业的高浓度氰化物废水提出采用沉淀一碱性氯化法解决方案。首先通过补充适量的亚铜离子使高浓度氰化物废水形成氰化亚铜沉淀,过滤后的滤液再用次氯酸钠氧化,废水达标排放,废渣回收利用。试验确定了处理高浓度氰化物废水最佳的操作条件为：当进水水质CN^-的质量浓度为71000mg／L时,亚硫酸过量14％,次氯酸钠投加量为废水中总氰的30倍,沉淀反应终点为pH值3．5,出水中CN^-的质量浓度不大于0．1mg／L。实际应用证明该方案是切实可行的．不仅安全、简单．而且时间短、费用低。     

F-在方解石表面的吸附及其对方解石表面性质的影响

氟元素主要存在于磷矿和萤石等矿物中,这些矿物中都伴生有方解石脉石矿物,在浮选分离的弱酸条件下,矿物表面的F^-会部分溶出并吸附到矿物表面,从而影响矿物表面性质。本文研究了F^-在方解石表面的吸附及其对方解石表面性质的影响机理。结果表明,在矿浆pH 值为5.5时,F^-以化学吸附的方式吸附在方解石表面,随着吸附时间的增加吸附量逐渐增加,90 min时方解石对F^-的吸附达到平衡。在油酸钠(NaOL)为捕收剂时,F^-的存在会降低方解石表面的疏水性。通过Zeta电位测试、溶液化学计算和X射线光电子能谱仪(XPS)分析表明,F^-会和方解石表面的Ca²⁺反应生成CaF₂沉淀,占据方解石表面的Ca位点,降低NaOL在方解石表面的吸附量。     

中草药美白防晒霜制备工艺的优化研究

以中草药当归、槐花蕾为初始原料,提取出有效成分作为天然添加剂制成中草药美白防晒霜。通过对配制工艺的探讨和产品的质量检测,证明产品具有良好的功效．质量符合要求,具有一定的推广价值。     

低蛋白天然胶乳的制备及性能研究

分别采用蛋白酶法、取代吸附法、多次离心法和普通离心法制备低蛋白天然胶乳(LPNRL)和普通天然胶乳(NRL),并对胶乳和硫化胶膜性能进行研究.结果表明,与NRL相比,LPNRL的氮含量、塑性初值和塑性保持率均较小;与NRL硫化胶膜相比,LPNRL硫化胶膜的物理性能、老化性能和玻璃化温度(Tg)较低,温度低于Tg时的储能模量较高.     

Na2CO3-K2CO3熔盐法同时制取合成气和金属锌

针对传统的甲烷转化制合成气及金属锌制备技术的缺陷,提出了一种新型的熔融盐反应体系,在熔融盐反应器中以熔融盐(质量比为1:1的Na2CO3/K2CO3)为反应介质对CH4与ZnO反应同时生成金属锌和合成气作了实验研究,利用气相色谱对气体组分进行了分析. 结果表明,反应尾气组分主要是H2, CO和CH4,未检测到CO2,其中合成气的量及H2/CO比例随反应温度的升高而增加,在1198 K左右获得了H2/CO比为2的合成气. 合成气和金属锌分别从气相和熔融盐中获得. 用XRD, SEM及EDS对金属锌产品和熔融盐进行了表征,发现反应后的熔融盐含有少量Na2O和NaOH,来自于CH4与熔融盐之间的微弱反应,由此推断熔融盐还具有消碳功能.     

第三代EGFR酪氨酸激酶抑制剂在非小细胞肺癌临床治疗中的应用及研究进展

表皮生长因子受体（EGFR）是非小细胞肺癌（NSCLC）靶向治疗最重要的靶点之一。目前,靶向EGFR突变的酪氨酸激酶抑制剂（TKIs）已发展至第三代,广泛用于治疗伴有EGFR敏感突变和伴有EGFR T790M耐药突变的NSCLC患者。然而,第三代EGFR TKIs用药过程中不可避免地会出现继发耐药,限制了该类药物的长期使用和临床治疗预后。本文首先围绕已上市或处于临床研究的第三代EGFR TKIs,重点综述了它们的作用特点和临床疗效。其次,从EGFR依赖性耐药和EGFR非依赖性耐药两个方面,归纳了第三代EGFR TKIs发生继发耐药的潜在机制。最后,针对EGFR依赖性耐药、EGFR非依赖性耐药和机制不明确的耐药,分别总结了可能有效的后续用药策略,以期为以EGFR为靶点的药物开发和临床应用提供借鉴和参考。